Mounting research suggests GLP-1 drugs, which are used to treat diabetes and obesity, may one day help people with alcohol ...

Although it's been used since the 1980s, naltrexone remains a relatively unknown treatment for alcohol dependency. Costing around £3 per pill, the drug blocks the "euphoric and sedative effects" of ...

Use of newer GLP-1 receptor agonists (semaglutide or tirzepatide) for obesity or diabetes by people with alcohol-use disorder was associated with a reduction in alcohol-related admissions to hospital, ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

As weight-loss drugs like Ozempic revolutionize weight loss, scientists hope they may also be life-changing for alcohol addiction. The drugs are one of several approaches doctors and psychiatrists ...

The U.S. can save lives from excess alcohol use without taking drastic measures. Here are 12 steps that can help.

A combination of two drugs- one for smoking cessation and another for depression- appear to work synergistically to treat alcohol use disorder. The corresponding study was published in The Lancet ...

The excessive and uncontrolled consumption of alcohol, which can culminate in the development of alcohol use disorder or alcoholism, is widespread in many countries worldwide. Individuals diagnosed ...

A drug that once showed promise as a treatment for alcohol use disorder did not work as expected, a new UCLA clinical trial found. "While ibudilast was not superior to the placebo, we saw that some ...

A common drug used for inflammatory skin conditions may hold the key to treating both alcohol addiction and pain sensitivity. That’s what scientists at a leading research institute have found. In a ...

Add Yahoo as a preferred source to see more of our stories on Google. When you buy through links on our articles, Future and its syndication partners may earn a commission. Naltrexone is relatively ...